Drug maker PharmaEssentia Corp (藥華醫藥) said yesterday that its new drug for polycythemia vera, a blood disorder of the bone marrow, could be approved in Europe at the end of 2015.
PharmaEssentia licensed the drug to Austrian company AOP Orphan Pharmaceuticals AG in 2009 and will receive milestone payments and royalties from AOP after the drug is approved in Europe and goes on sale.
The drug has completed the second phase of clinical trials in Europe, and PharmaEssentia said it will discuss the European trial data with the US Food and Drug Administration to expedite the approval process to the US.
“We aim to launch the drug in the US and Europe at the beginning of 2016,” company president and chief executive officer Lin Ko-chung (林國鐘) said.
Sales of the drug are expected to reach US$500 million in both the US and Europe, benefiting from higher prices set by both regions as an incentive for drug companies to develop orphan drugs, Lin said.
The company has three patents for the new drug, which will expire in 2028, 2029 and 2030 respectively.
PharmaEssentia built a factory in Central Taiwan Science Park (中部科學園區) last year which has the capacity to produce 1 million units of the drug a year.
In April, the factory won regulatory approval by Taiwan and European medicine agencies for its quality manufacturing process, the company said.
Lin said the company plans to list on the smaller Emerging Stock Market in November or December, and will shift to list on GRETAI Securities Market or Taiwan Stock Exchange next year.
Nutek Corp (閎泰), which manufactures automotive security systems, is the company’s largest shareholder with a 20 percent stake, Lin said, adding that it counts Toyota Motor Corp as one of its major clients.
State-run National Development Fund owns a stake in PharmaEssentia of 12 percent to 13 percent, he said.
Meanwhile, another drug manufacturer SynCore Biotechnology Co (杏國新藥) debuted its shares on the Emerging Stock Market yesterday, seeing its shares rise to NT$114.98 from the initial pubilc offering price of NT$60.
The company's Veregen drug for genital warts has won government's approval and can contribute to its sales starting this quarter, SynCore said.
FALLING BEHIND: Samsung shares have declined more than 20 percent this year, as the world’s largest chipmaker struggles in key markets and plays catch-up to rival SK Hynix Samsung Electronics Co is laying off workers in Southeast Asia, Australia and New Zealand as part of a plan to reduce its global headcount by thousands of jobs, sources familiar with the situation said. The layoffs could affect about 10 percent of its workforces in those markets, although the numbers for each subsidiary might vary, said one of the sources, who asked not to be named because the matter is private. Job cuts are planned for other overseas subsidiaries and could reach 10 percent in certain markets, the source said. The South Korean company has about 147,000 in staff overseas, more than half
Taipei is today suspending its US$2.5 trillion stock market as Super Typhoon Krathon approaches Taiwan with strong winds and heavy rain. The nation is not conducting securities, currency or fixed-income trading, statements from its stock and currency exchanges said. Yesterday, schools and offices were closed in several cities and counties in southern and eastern Taiwan, including in the key industrial port city of Kaohsiung. Taiwan, which started canceling flights, ship sailings and some train services earlier this week, has wind and rain advisories in place for much of the island. It regularly experiences typhoons, and in July shut offices and schools as
TECH PARTNERSHIP: The deal with Arizona-based Amkor would provide TSMC with advanced packing and test capacities, a requirement to serve US customers Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) is collaborating with Amkor Technology Inc to provide local advanced packaging and test capacities in Arizona to address customer requirements for geographical flexibility in chip manufacturing. As part of the agreement, TSMC, the world’s biggest contract chipmaker, would contract turnkey advanced packaging and test services from Amkor at their planned facility in Peoria, Arizona, a joint statement released yesterday said. TSMC would leverage these services to support its customers, particularly those using TSMC’s advanced wafer fabrication facilities in Phoenix, Arizona, it said. The companies would jointly define the specific packaging technologies, such as TSMC’s Integrated
An Indian factory producing iPhone components resumed work yesterday after a fire that halted production — the third blaze to disrupt Apple Inc’s local supply chain since the start of last year. Local industrial behemoth Tata Group’s plant in Tamil Nadu, which was shut down by the unexplained fire on Saturday, is a key linchpin of Apple’s nascent supply chain in the country. A spokesperson for subsidiary Tata Electronics Pvt yesterday said that the company would restart work in “many areas of the facility today.” “We’ve been working diligently since Saturday to support our team and to identify the cause of the fire,”
RSS